-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Behavioral variant frontotemporal dementia (bvFTD) is a neurodegenerative disease characterized by atrophy of the frontal and anterior temporal lobes
The hexanucleotide amplification of the non-coding region of C9ORF72 was found to be the most common genetic abnormality in bvFTD and amyotrophic lateral sclerosis (ALS)
In this study, we investigated whether carriers of the C9orf72RE mutation had certain personal and/or behavioral characteristics in their lives before the onset of bvFTD symptoms
Research flow chart
Research flow chartThe results showed that there were no significant differences between carriers and non-carriers in terms of education, occupation type, and number of intimate partners
For the first time, this study conducted an in-depth discussion on the course of patients with C9orf72RE bvFTD, revealing that bvFTD patients may have subtle personality characteristics in the early life
For the first time, this study conducted an in-depth discussion on the course of patients with C9orf72RE bvFTD, revealing that bvFTD patients may have subtle personality characteristics in the early life
.
GossinkF.
,DolsA ,StekML GossinkF.
Gossink DolsA Dols StekML Stek , et Al Early involvement in C9orf72 REPEAT Expansion Life Carriers Journal of.
Neurology, Neurosurgery & PsychiatryPublished Online First:27 April 2021.
Published Online First: DOI:10.
1136 /jnnp-2020-325994 doi:
leave a message here